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A B S T R A C T
Enteric viruses including hepatitis E virus (HEV), human norovirus (HuNV), and rotavirus are causing global
health issues. The host interferon (IFN) response constitutes the first-line defense against viral infections.
Melanoma Differentiation-Associated protein 5 (MDA5) is an important cytoplasmic receptor sensing viral in-
fection to trigger IFN production, and on the other hand it is also an IFN-stimulated gene (ISG). In this study, we
investigated the effects and mode-of-action of MDA5 on the infection of enteric viruses. We found that MDA5
potently inhibited HEV, HuNV and rotavirus replication in multiple cell models. Overexpression of MDA5 in-
duced transcription of important antiviral ISGs through IFN-like response, without triggering of functional IFN
production. Interestingly, MDA5 activates the expression and phosphorylation of STAT1, which is a central
component of the JAK-STAT cascade and a hallmark of antiviral IFN response. However, genetic silencing of
STAT1 or pharmacological inhibition of the JAK-STAT cascade only partially attenuated the induction of ISG
transcription and the antiviral function of MDA5. Thus, we have demonstrated that MDA5 effectively inhibits
HEV, HuNV and rotavirus replication through provoking a non-canonical IFN-like response, which is partially
dependent on JAK-STAT cascade.
1. Introduction
There are over 100 types of viruses excreted in feces, which col-
lectively known as enteric viruses. Among these, hepatitis E virus (HEV)
has been recognized as an emerging zoonotic virus, representing a
major cause of acute hepatitis worldwide. Although it is often self-
limiting, high mortality rate has been reported in pregnant women.
Human norovirus (HuNV) and rotavirus are the leading causes of acute
gastroenteritis. Interestingly, all three types of viruses can cause chronic
infection in immunocompromised organ transplantation patients
(Kamar et al., 2008; Zhou et al., 2013; Bok and Green, 2012; Yin et al.,
2015), highlighting the essential role of host immunity in determining
the outcome of these infections.
Innate immune system is the first line of host defense against viral
infection and plays a critical role in clearance of pathogen (Medzhitov
and Janeway, 2000). Upon infection, pathogen-associated molecular
patterns (PAMPs) are recognized by pattern recognition receptor
(PRRs), such as toll-like receptors (TLRs) and retinoic acid inducible
gene I (RIG-I)-like receptors (RLRs) (O'Neill and Bowie, 2010; Jensen
and Thomsen, 2012). Subsequently, PPRs initiate downstream signaling
pathway to produce a panel of cytokines, in particular, the antiviral
IFNs. Mechanistically, type I and III IFN bind to their receptors on the
cell surface to initiate signal cascades. This binding triggers the phos-
phorylation of STAT1 and STAT2, which subsequently bind to IRF9 to
form a IFN-stimulated gene factor 3 (ISGF3) complex. ISGF3 translo-
cates to the nucleus to drive expression of IFN-stimulated genes (ISGs)
to establish antiviral states (Schneider et al., 2014).
Melanoma Differentiation-Associated protein 5 (MDA5) is an
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important cytoplasmic receptor, a member of RLRs, which participates
in recognition of different RNA viruses. Upon the detection of viral RNA
ligand, MDA5 recruits mitochondrial antiviral signaling (MAVS, also
known as IPS-1, VISA, or Cardif) (Seth et al., 2005) to activate IRF3/7
and NF-κB, and eventually triggers IFN and inflammatory responses. On
the other hand, MDA5 is also an important antiviral ISG. MDA5 has
been reported to potently inhibit the replication of Sindbis virus (SINV),
West Nile virus (WNV) and Venezuelan equine encephalitis virus
(VEEV) (Schoggins et al., 2011). The antiviral mechanisms may directly
through pathogen recognition pathway or directly act as an antiviral
ISG. However, how MDA5 exactly exerts antiviral action against dif-
ferent types of viruses remains largely under investigated.
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Given the importance of MDA5 in innate antiviral defense, we in-
vestigated the effects and mechanism-of-actions of MDA5 in enteric
virus infections. We found that overexpression of MDA5 effectively
inhibited HEV, HuNV, and rotavirus replication. Mechanistically,
MDA5 activated STAT1 phosphorylation and the transcription of anti-
viral ISGs, but dispensable of the production of functional IFNs.
Surprisingly, STAT1 deficient only partially impaired the antiviral ac-
tivity and ISG transcription induced by MDA5. These results have de-
monstrated the broad antiviral activity of MDA5 against enteric viruses,
involving non-canonical mechanisms partially through the JAK-STAT
cascade.
2. Materials and methods
2.1. Reagents
Human IFN-α (Sigma-Aldrich, H6166) was dissolved in PBS. Stocks
of JAK inhibitor 1 (SC-204021, Santa Cruz Biotechnology, Santa Cruz,
CA, USA) were dissolved in DMSO with a final concentration of 5 mg/
ml. Dimethyl sulfoxide (DMSO, Sigma, Zwijndrecht, the Netherlands)
was used as vehicle control. Phospho-STAT1 (Tyr701) (58D6, Rabbit
mAb, 9167), STAT1 (Rabbit mAb, 9172), RIG-I (D14G6, Rabbit
mAb,3743), PKR (D7F7, Rabbit mAb, 12297), MDA5 (IFIH1) (D74E4,
Rabbit mAb, 5321) antibodies were obtained from Cell Signaling
Technology (Danvers, MA, USA). β-actin antibody (mouse monoclonal,
sc-47778) was obtained from Santa Cruz Biotechnology (Santa Cruz,
CA, USA). Anti-rabbit and anti-mouse IRDye-conjugated secondary
antibodies (Li-Cor Biosciences, Lincoln, NE, USA) were also used.
2.2. Cell culture
Huh7 and PLC/PRF/5 (PLC) human hepatoma cells, Huh7-STAT1
knockout cells, HEK293T cells and Caco2 cells were cultured in DMEM
(Lonza Biowhittaker, Verviers, Belgium) complemented with 10% (v/v)
fetal calf serum (FCS) (Hyclone, Logan, UT, USA), 100 IU/ml penicillin
and 100 mg/ml streptomycin. For the ISRE reporter model (Huh7-ISRE-
Luc), Huh7 cells were transduced with a lentiviral transcriptional re-
porter system expressing the firefly luciferase gene driven by a pro-
moter containing multiple ISRE promoter elements (SBI Systems
Biosciences, Mountain View, CA, USA). Luciferase activity represents
ISRE promoter activation (Pan et al., 2012).
2.3. Viruses and cell culture models
In this study, multiple cell lines were used for HEV replication, in-
cluding human hepatoma cell lines, Huh7 and PLC. For the full-length
HEV model, a plasmid construct containing the full-length HEV genome
(Kernow-C1 p6 clone; GenBank Accession Number JQ679013) was used
to generate HEV genomic RNA with the Ambion mMessage mMachine
in vitro RNA transcription Kit (Thermo Fisher Scientific Life Sciences).
Huh7 and PLC cells were electroporated with full-length HEV genome
RNA, to generate consecutive HEV-infected cell models, Huh7-p6 and
PLC-p6. For the subgenomic HEV model, a construct containing sub-
genomic HEV in which the portion of HEV ORF2 was replaced with the
in-frame Gaussia princeps luciferase reporter gene to yield p6-Luc
(Shukla et al., 2012). Huh7 cells were electroporated with HEV sub-
genomic RNA to generate an HEV subgenomic model, Huh7-p6-Luc, in
which the accumulation of secreted luciferase serves as a reporter for
HEV replication. HG23 model is based on Huh7 cells containing a stable
subgenomic HuNV replicon (Chang et al., 2006). Gentamicin (G418;
Gibco) was added to HG23 culture medium at 1.5 mg/mL for selection
before experimentation.
2.4. Gene knockdown and overexpression by lentiviral vectors or plasmid
For gene knockdown, pLKO.1-based lentiviral vectors (Sigma-
Aldrich) targeting MDA5 and non-targeted control vector (shCTR) were
obtained from the Biomics Center in Erasmus Medical Center. Lentiviral
pseudoparticles were generated in HEK293T cells. To generate a stable
gene-knockdown cell line, PLC cells were transduced with lentiviral
particles for 48 h. Subsequently, transduced cells were cultured with
medium containing 2.5 mg/ml puromycin (Sigma-Aldrich). Because the
vectors also express a puromycin resistance gene, cell lines showing
optimal gene knockdown after selection were chosen.
pTRIP.CMV.IVSb.ISG.ires.TagRFP-based MDA5 overexpression vector
was a kind gift from Prof. Charles M. Rice (Rockefeller University, New
York, NY, USA) (Schoggins et al., 2011). Meanwhile, Photinus pyralis
luciferase (Fluc) was used as the control (also kind gifts from Prof.
Charles M. Rice). Target cell lines were seeded into 12-well plates at a
density of 6 × 104 cells per well and transduced with lentiviral pseu-
doparticles at 37 °C for 24, 48, or 72 h. The transduction time of each
experiment is described in the legend of each figure, along with the
control vector used. The MDA5 plasmid was also used for direct
transfection to overexpress MDA5.
2.5. Quantification of viral replication
HEV, HuNV and rotavirus RNA levels were quantified by SYBR-
Green-based qRT-PCR (Applied Biosystems SYBR Green PCR Master
Mix; Thermo Fisher Scientific Life Sciences) with the StepOnePlus
System (Thermo Fisher Scientific Life Sciences). GAPDH was used as
housekeeping genes, and all gene expression levels (relative) were
normalized to GAPDH using the 2-ΔΔCt method. For HEV-related Gaussia
luciferase analysis (HEV-p6-Luc), the activity of secreted luciferase in
the cell culture medium was measured by BioLux Gaussia Luciferase
Flex Assay Kit (New England Biolabs, Ipswich, MA, USA), according to
Fig. 1. MDA5 inhibits the replication of different enteric viruses. (A) Quantitative RT-PCR analysis and immunoblot analysis of MDA5 expression in Huh7-p6
cells transduced with MDA5 or Fluc vector or treated with IFN-α (1000 IU/mL) for 48 h (n = 13). (B) Quantitative RT-PCR analysis and immunoblot analysis of HEV
RNA level and HEV ORF2 protein level in Huh7-p6 cells transduced with MDA5 or Fluc vector or treated with IFN-α (1000 IU/mL) for 48 h (n = 6–9). (C) Analysis of
HEV-related Gaussia luciferase activity in Huh7-p6-luciferase cells transduced with MDA5 or Fluc vector or treated with IFN-α (1000 IU/mL) for 24, 48, or 72 h
(n = 6–10). (D) Huh7-p6 cells transduced with lentiviral short hairpin RNA vector targeting MDA5 or scramble control. Quantitative RT-PCR analysis of MDA5
expression level and HEV RNA level in stable MDA5 knockdown or scramble control Huh7-p6 cells (n = 4). (E) Quantitative RT-PCR analysis and immunoblot
analysis of MDA5 and HEV expression in PLC-p6 cells transduced with MDA5 or Fluc vector or treated with IFN-α (1000 IU/mL) for 48 h (n = 6–9). (F) PLC-p6 cells
transduced with lentiviral short hairpin RNA vector targeting MDA5 or scramble control. Quantitative RT-PCR analysis of MDA5 expression level and HEV RNA level
in stable MDA5 knockdown or scramble control PLC-p6 cells (n = 10). (G) Quantitative RT-PCR analysis of MDA5 expression and rotavirus RNA level in Caco2 cells
transduced with MDA5 or Fluc vector or treated with IFN-α (1000 IU/mL) for 48 h (n = 6–14). (H) Caco2 cells transduced with lentiviral short hairpin RNA vector
targeting MDA5 or scramble control. Stable MDA5 knockdown or scramble control Caco2 cells were infected with rotavirus for 48 h. Quantitative RT-PCR analysis of
MDA5 expression level and rotavirus RNA level (n = 4–6). (I) Quantitative RT-PCR analysis of MDA5 expression and HuNV RNA level in HG23 (Huh7-based HuNV
replicon) cells transduced with MDA5 or Fluc vector or treated with IFN-α (1000 IU/mL) for 48 h (n= 4–12). (J) HG23 cells (Huh7-based HuNV replicon) transduced
with lentiviral short hairpin RNA vector targeting MDA5 or scramble control. Quantitative RT-PCR analysis of MDA5 expression level and HuNV RNA level in stable
MDA5 knockdown or scramble control Huh7 cells (n = 4). Data were normalized to the Fluc or untreated control CTR (Fluc/CTR, set as 1) or to the scramble control
(shCTR, set as 1). Data are means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001. Abbreviation: Flu, Photinus pyralis luciferase; CTR, control; RLU, relative
luciferase unit; sh, short hairpin.
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the manufacturer's instructions. Luciferase activity was quantified with
a LumiStar Optima luminescence counter (BMG Lab Tech, Offenburg,
Germany). For the firefly and Photinus pyralis luciferases, luciferin
potassium salt (100 mM; Sigma-Aldrich) was added to the cells and
incubated for 10 min at 37 °C, and luciferase activity was measured.
2.6. IFN production bioassay
Cells were seeded into 6-well plates at a density of 1 × 105 cells per
well and transduced with MDA5 or control lentiviral particles at 37 °C.
After 72 h, lentiviral particles were removed, and cells were washed 3
times with PBS and cultured for another 72 h. The cultured supernatant
Fig. 2. MDA5 triggers the transcription of a range of antiviral ISGs. (A) Analysis of ISRE-related firefly luciferase activity in Huh7-ISRE-Luc cells transduced with
MDA5 or Fluc vector or treated with IFN-α (1000 IU/mL) for 48 h (n = 9). (B) Quantitative RT-PCR analysis of ISG mRNA level in Huh7-p6 cells, (C) PLC-p6 cells,
and (D) Caco2 cells transduced with MDA5 or Fluc vector for 48 h (n = 4–6). (E) Immunoblot analysis of ISG protein level in Huh7-p6 cells, (F) PLC-p6 cells, and (G)
Caco2 cells transduced with MDA5 or Fluc vector for 48 or 72 h (n = 3). Data were normalized to the Fluc control (Fluc, set as 1). Data are means ± SEM.
*P < 0.05; **P < 0.01; ***P < 0.001. Abbreviation: Flu, Photinus pyralis luciferase.
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was subsequently collected and filtered through a 0.45 μm pore size
membrane and added to Huh7-ISRE-Luc reporter cells which are sen-
sitive to IFNs.
2.7. Immunoblot analysis
Lysate was heated at 95 °C for 5 min. Proteins were subjected to a
10% sodium dodecyl sulfate polyacrylamide gel (SDS-PAGE), separated
at 100 V for 100 min, and electrophoretically transferred onto a PVDF
membrane (pore size: 0.45 μm; Thermo Fisher Scientific Life Sciences)
for 100 min with an electric current of 230 mA. Subsequently, the
membrane was blocked with blocking buffer (Li-Cor Biosciences) in PBS
containing 0.05% Tween-20. Membranes were incubated with primary
antibodies overnight at 4 °C. Rabbit anti-MDA5 (1:1000), p-STAT1
(1:1000), STAT1 (1:1000), RIG-I (1:1000), PKR (1:1000) antibodies or
mouse anti-β-actin (1:1000) were diluted in blocking buffer. The
membrane was washed 3 times, followed by incubation for 1 h with
anti-rabbit or anti-mouse IRDye-conjugated secondary antibodies
(1:5000; Li-Cor Biosciences) at room temperature. β-actin served as the
loading standard. The membrane was scanned by Odyssey Infrared
Imaging System (Li-Cor Biosciences). Results were visualized with
Odyssey 3.0 software. Band intensity data of each immunoblot was also
quantified by Odyssey Software.
2.8. MTT assay
Cells were seeded in 96-well plates, and 10 mM 3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma-
Aldrich) was added. The plate was incubated at 37 °C with 5% CO2 for
3 h, then the medium was removed. After adding 100 μL of DMSO to
each well, the plate was incubated at 37 °C for 1 h. The absorbance was
read on the microplate absorbance reader (Bio-Rad, Hercules, CA, USA)
at a wavelength of 490 nm.
2.9. Statistical analysis
GraphPad Prism 5 software was used for data analysis using a Mann-
Whitney test. All results were presented as mean ± standard errors of
the means (SEM). P values of less than 0.05 (single asterisks in figures)
were considered statistically significant; whereas P values less than 0.01
(double asterisks) and 0.001 (triple asterisks) were considered highly
significant.
Fig. 3. MDA5 overexpression does not induce the production of functional IFNs. (A) Quantitative RT-PCR analysis of IFN gene mRNA level in Huh7-p6 cells (B)
PLC-p6 cells and (C) Caco2 cells transduced with MDA5 or Fluc vector for 48 h (n = 6–12). (D) Production of conditioned medium (supernatant). Cells were
transduced with MDA5 or Fluc (control) vector for 72 h; then, the cells were washed three times, and medium was refreshed. Cells were cultured for another 72 h,
and supernatant was collected as conditioned medium. (E) Analysis of ISRE-related firefly luciferase activity in Huh7-ISRE-Luc cells treated with conditioned medium
from Huh7-p6 cells (F) PLC-p6 cells and (G) Caco2 cells or various concentrations of IFN-α for 48 h (n = 9–18). Data were normalized to the Fluc control (Fluc, set as
1). Data are means ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001; Abbreviation: ns, not significant; CTR, control; RLU, relative luciferase unit.
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3. Results
3.1. MDA5 potently inhibits HEV, HuNV and rotavirus replication
To evaluate the effects of MDA5 on enteric viruses, we employed
multiple cell culture models of HEV, HuNV and rotavirus infections. For
HEV, two Huh7-based HEV models (Huh7-p6 and Huh7-p6-Luc) were
used. Lentiviral mediated MDA5 overexpression was confirmed in
Huh7-p6 cells at mRNA and protein levels (Fig. 1A). In both HEV in-
fectious and replicon models, MDA5 overexpression significantly in-
hibited HEV replication (Fig. 1B, C). Conversely, gene silencing of
MDA5 by RNAi significantly facilitated HEV replication (Fig. 1D) in
Huh7 cells. We also confirmed the anti-HEV activity of MDA5 in PLC
cells (Fig. 1E, F).
To validate the antiviral ability of MDA5 in other enteric viruses, we
overexpressed MDA5 in rotavirus infected Caco2 cells. The results
showed that MDA5 potently inhibited rotavirus replication (Fig. 1G),
and the antiviral activity is comparable to IFN-α treatment. Conversely,
Gene silencing of MDA5 in Caco2 cells significantly increased rotavirus
replication (Fig. 1H). Overexpression and knockdown of MDA5 in
HG23 cells further demonstrated the anti-HuNV activity of MDA5.
These results have demonstrated that MDA5 has a broad antiviral ac-
tivity against enteric viruses, and encouraged us to further explore the
mechanism-of-action.
3.2. MDA5 triggers the transcription of a range of antiviral ISGs through
IFN-like response
In general, IFNs active ISGF3 complex, which binds to IFN-
stimulated response element (ISRE) motifs in nucleus to drive ISG
transcription. Usually upon sensing of particular viruses, MDA5 triggers
IFN production, which subsequently induce ISG expression. Here, we
employed a transcriptional report system that mimics IFN response
with a reporter luciferase gene that was driven by multiple ISRE (ISRE-
Luc). Surprisingly, similar to IFN-α treatment, MDA5 overexpression in
naïve cells already potently increased ISRE-luciferase activity (Fig. 2A).
Activation of ISRE leads to the transcription of ISGs that contain this
motifs in their promoter regions. Consistently, MDA5 overexpression
stimulated the transcription of a large panel of ISGs in Huh7, PLC and
Caco2 cells (Fig. 2B, C, and 2D). The transcription level of ISGs induced
by MDA5 is similar to that by IFN-α treatment (Supporting Fig. 1A, B,
and 1C), whereas the induction patterns are different. The expression of
several important ISGs was further confirmed by immunoblotting at
protein level (Fig. 2E, F, and 2G). Since all these experiments are based
on lentiviral vector mediated MDA5 overexpression, we next attempted
to verify these findings by plasmid-based gene delivery. Consistently,
transfection of plasmid expressing MDA5 into Huh7-p6 cells resulted in
inhibition of HEV replication and induction of many antiviral ISGs
(Supporting Fig. 1D). These results suggested that MDA5 induces ISG
expression through triggering IFN-like response.
3.3. Overexpression of MDA5 does not induce the production of functional
IFNs
Since MDA5 induced antiviral ISG transcription through IFN-like
response, we examined whether MDA5 overexpression triggers IFN
production. At mRNA level, MDA5 overexpression did not induce IFN-α
and IFN-β, but moderately induced IFN-λ expression in Huh7, PLC and
Fig. 4. MDA5 overexpression activates STAT1 expression and phosphorylation. (A) Quantitative RT-PCR analysis of STAT1 mRNA level in Huh7-p6 cells (B)
PLC-p6 cells and (C) Caco2 cells transduced with MDA5 or Fluc vector for 48 h (n = 4–12). (D) Immunoblot analysis of STAT1 expression in Huh7-p6 cells (E) PLC-p6
cells and (F) Caco2 cells transduced with MDA5 vector or treated with IFN-α (1000 IU/Ml) for 48 or 72 h (n = 3). (G) Immunoblot analysis of p-STAT1 (Tyr701)
expression in Huh7-p6 cells (H) PLC-p6 cells and (I) Caco2 cells transduced with MDA5 vector or treated with IFN-α (1000 IU/Ml) for 48 or 72 h (n = 3). Data were
normalized to the Fluc/CTR control (Fluc/CTR, set as 1). Data are means ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001; Abbreviation: Flu, Photinus pyralis
luciferase; CTR, control.
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Fig. 5. JAK inhibitor 1 partially attenu-
ates MDA5-induced ISG transcription
and anti-HEV activity. (A) Immunoblot
analysis of p-STAT1 (Tyr701) expression
and ISG protein levels in Huh7 cells trans-
duced with MDA5 vector or treated with
IFN-α (1000 IU/mL) or JAK inhibitor 1
(10 μM) for 48 h (n = 3). (B) Quantitative
RT-PCR analysis of MDA5 mRNA levels in
Huh7 cells transduced with MDA5 vector or
treated with IFN-α (1000 IU/mL) or JAK
inhibitor 1 (10 μM) for 48 h (n = 6–8). (C)
Analysis of HEV-related Gaussia luciferase
activity in Huh7-p6-luciferase cells trans-
duced with MDA5 or Fluc vector or treated
with IFN-α (1000 IU/mL) or JAK inhibitor 1
(10 μM) for 48 h (n = 6–9). (D) Analysis of
ISRE-related firefly luciferase activity in
Huh7-ISRE-Luc cells transduced with MDA5
or Fluc vector or treated with IFN-α (1000
IU/mL) or JAK inhibitor 1 (10 μM) for 48 h
(n = 9). (E) Quantitative RT-PCR analysis
of ISG mRNA levels in Huh7 cells trans-
duced with MDA5 vector or Fluc control or
JAK inhibitor 1 (10 μM) for 48 h (n = 4–6).
(F) Immunoblot analysis of p-STAT1
(Tyr701) expression and ISG protein levels
in PLC cells transduced with MDA5 vector
or treated with IFN-α (1000 IU/mL) or JAK
inhibitor 1 (10 μM) for 48 h (n = 3). (G)
Quantitative RT-PCR analysis of MDA5
mRNA levels in PLC cells transduced with
MDA5 vector or treated with IFN-α (1000
IU/mL) or JAK inhibitor 1 (10 μM) for 48 h
(n = 6–9). (H) Quantitative RT-PCR ana-
lysis of ISG mRNA levels in PLC cells
transduced with MDA5 vector or Fluc con-
trol or JAK inhibitor 1 (10 μM) for 48 h
(n = 4–6). Data were normalized to the
Fluc control (Fluc, set as 1). Data are
means ± SEM. *P < 0.05; **P < 0.01;
***P < 0.001; Abbreviation: ns, not sig-
nificant; Flu, Photinus pyralis luciferase.
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Caco2 cells (Fig. 3A 3B, and 3C). More importantly, we investigated
whether there is production of functional IFNs by testing conditioned
medium (supernatant) from MDA5 overexpressed Huh7, PLC or Caco2
cells (Fig. 3D). In the ISRE-based IFN reporter assay, treatment with
these conditioned medium did not trigger ISRE activation (Fig. 3E, F,
and 3G). These results demonstrated that MDA5 overexpression does
not trigger the production of functional IFNs in these cell models.
3.4. Overexpression of MDA5 upregulates STAT1 expression and
phosphorylation
Given the dispensability of IFN production in MDA5-triggered IFN-
like response, we next investigated the effect on STAT1, a central
component of the JAK-STAT cascade. At mRNA level, similar to IFN-α
treatment, MDA5 overexpression significantly upregulated STAT1 ex-
pression in Huh7, PLC and Caco2 cells (Fig. 4A, B, and 4C). This was
further confirmed at total protein levels of STAT1 in these cell models
(Fig. 4D, E, and 4F).
Phosphorylation of STAT1 is hallmark of IFN-triggered activation of
JAK-STAT cascade. We found the activation of p-STAT1, at 701 site, by
MDA5 overexpression, similar to IFN-α treatment (Fig. 4G, H, and 4I).
3.5. The effect of JAK-STAT pathway on MDA5-mediated antiviral ability
and triggered ISG transcription
Because MDA5 activates STAT1 expression and phosphorylation, we
further investigated the role of JAK-STAT pathway on MDA5-mediated
ISG transcription and antiviral activity. We firstly used JAK inhibitor 1
to pharmacologically block the JAK-STAT pathway. As expected, MDA5
or IFN-α-induced STAT1 phosphorylation was effectively blocked by
JAK inhibitor (Fig. 5A), whereas lentiviral-delivered MDA5 over-
expression was not affected by the inhibitor in Huh7 cells (Fig. 5A, B).
Surprisingly, the anti-HEV activity of MDA5 was only partially atte-
nuated, whereas the anti-HEV activity of IFN-α was totally blocked by
JAK inhibitor 1 (Fig. 5C). Consistently, MDA5-induced ISRE activation
was hardly affected by this inhibitor, whereas ISRE activation induced
by IFN-α was totally blocked (Fig. 5D). Subsequently, we measured the
mRNA level of many antiviral ISGs in MDA5-overexpressed Huh7 cells
treated with JAK inhibitor 1. Expectedly, the expression of ISGs was
minor affected by the inhibitor (Fig. 5E). In contrast, IFN-α-induced ISG
transcription was totally blocked by the inhibitor (Supporting Fig. 2A).
Similar results were observed in PLC cells (Fig. 5F, G, 5H, and sup-
porting Fig. 2B).
To further confirm, we overexpressed MDA5 in STAT1 knockout
(STAT1−/−) and wild type Huh7 cells (Fig. 6A, B). Although MDA5
failed to induce p-STAT1 in STAT1−/− cells (Fig. 6B), it induced a si-
milar level of ISG transcription compared to wild type Huh7 cells
(Fig. 6C). In contrast, IFN-α failed to induce ISGs in STAT1−/− cells
(Supporting Fig. 3A).
Next, we explored the effects of JAK-STAT pathway on MDA5
mediated anti-HuNV and anti-rotavirus activity. Pharmacologically
blocking the JAK-STAT pathway by JAK inhibitor 1 in Caco2 and
HG23 cells only had minor effect on the anti-HuNV and anti-rotavirus
ability of MDA5 (Fig. 7A, B). However, the antiviral ability of IFN-α was
Fig. 6. MDA5-induced ISG transcription was not affected in STAT1 knockout cells. (A) Quantitative RT-PCR analysis of MDA5 mRNA levels in WT and STAT1−/
− Huh7 cells transduced with MDA5 vector or Fluc control for 48 h (n = 4–9). (B) Immunoblot analysis of ISG protein level in WT and STAT1−/− Huh7 cells
transduced with MDA5 vector or Fluc control for 48 h (n = 3). (C) Quantitative RT-PCR analysis of ISG mRNA levels in WT and STAT1−/− Huh7 cells transduced
with MDA5 vector or Fluc for 48 h (n = 4). Data were normalized to the Fluc/CTR control (Fluc/CTR, set as 1). Data are means ± SEM. *P < 0.05; **P < 0.01;
***P < 0.001. Abbreviation: ns, not significant; Flu, Photinus pyralis luciferase; CTR, control.
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Fig. 7. MDA5 inhibits rotavirus and HuNV replication and induced ISG transcription partially via JAK-STAT pathway (A) Quantitative RT-PCR analysis of
MDA5 mRNA levels or rotavirus RNA level in Caco2 cells transduced with MDA5 vector or treated with IFN-α (1000 IU/mL) or JAK inhibitor 1 (10 μM) for 48 h
(n = 6–9). (B) Quantitative RT-PCR analysis of MDA5 mRNA levels or HuNV RNA level in HG23 cells transduced with MDA5 vector or treated with IFN-α (1000 IU/
mL) or JAK inhibitor 1 (10 μM) for 48 h (n = 4). (C) Quantitative RT-PCR analysis of ISG mRNA levels in Caco2 cells or (D) HG23 (Huh7-based HuNV replicon) cells
transduced with MDA5 vector or treated with IFN-α (1000 IU/mL) or JAK inhibitor 1 (10 μM) for 48 h (n = 6). Data were normalized to the Fluc control (Fluc, set as
1). Data are means ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001. Abbreviation: ns, not significant; Flu, Photinus pyralis luciferase.
Y. Li, et al. Antiviral Research 176 (2020) 104743
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completely blocked by this inhibitor. We observed similar results on the
induction of ISGs by MDA5 or IFN-α (Fig. 7C, D, and supporting Fig. 4A,
B). Collectively, these results demonstrated that the induction of ISG
transcription and the anti-enteric virus activity of MDA5 only partially
depend on JAK-STAT cascade.
4. Discussion
This study has demonstrated that MDA5 is a abroad antiviral factor
against enteric virus infection, including HEV, HuNV and rotavirus.
Overexpression of MDA5 induces the phosphorylation of STAT1 and
triggers the transcription of a panel of antiviral ISGs, without the re-
quirement of functional IFN production. Knockout or pharmacological
inhibition of STAT1 only partially blocked the induction of ISG tran-
scription and the antiviral activity of MDA5.
The innate immune system is the first line of defense against viral
infections. One predominant characteristic is the rapid and spectrum of
resistance to infection through recognition of viral components by host
PRRs, which initiate signal cascade transduction that triggers the pro-
duction and secretion of IFNs. Subsequently, IFNs stimulate transcrip-
tion of ISGs through JAK-STAT pathway to establish antiviral state.
Among them, only a small subset of ISGs have antiviral effects
(Schoggins et al., 2011). Previous studies have shown that MDA5 plays
an important role in defending against a wide range of viral infections
(Dang et al., 2018; Lu and Liao, 2013; Zhang et al., 2018; Cao et al.,
2015). Consist with these reports, we found that MDA5 significantly
inhibits enteric viruses replication in multiple cell models.
MDA5 is a main cytoplasmic sensor, which recognizes the viral RNA
to trigger downstream antiviral signaling (Zhang et al., 2018; Cao et al.,
2015; Kuo et al., 2013; Wei et al., 2014). Classically, viral infection
induces MDA5 activation and mediates IFNs production through MAVS-
IRF3 signal pathway. Several studies have demonstrated that MDA5
induces IFN-α or INF-β production during viral infection (Zhang et al.,
2018; Pham et al., 2016). In turn, IFNs combat viral infection and exert
immune regulatory roles through induction of ISGs. In this study, we
found that MDA5 induced transcription and protein expression of many
ISGs, and most of these have been reported to have antiviral activity
(Schoggins et al., 2011, 2014; Xu et al., 2016, 2017). However, the
expression pattern of ISGs induced by MDA5 is different from IFN-α
treatment. For instance, in Huh7 cells, overexpression of MDA5 highly
activates the expression of IFIT2, IFIT3 and CXCL10, whereas the ex-
pression of PKR and IFI27 is highly activated by IFN-α treatment. This
indicates non-canonical mechanisms of MDA5 mediated ISG transcrip-
tion independent of IFN. Although IFN has been used as therapeutic
agent for treating infectious diseases for many decades (Finter et al.,
1991; Rijckborst and Janssen, 2010). However, it is often associated
with substantial side effects partially related to the induction of pro-
inflammatory ISGs. Furthermore, many patients do not adequately re-
spond to the treatment, which is partially associated with the induction
of ISGs functioning as negative regulators. Among these ISGs, the high
level induction of ISG15 has been well-recognized to affect the treat-
ment outcome of patients co-infected with HIV and HCV (Katsounas
et al., 2013; Nick et al., 2016). The distinct mechanisms of MDA5 in ISG
induction may implicate as a new avenue for developing antiviral
strategies with better specificity and less side effects.
For rotavirus infection, it has been reported that MDA5 and RIG-I
are important sensors to trigger IFN response through MAVS, whereas
MDA5 silencing significantly decreased IFN production (Broquet et al.,
2011). However, we have previously demonstrated that in culture of
intestinal epithelial cell line or organoids, infection of rotavirus in-
creased IFN gene transcription, but not the production of IFN proteins
(Hakim et al., 2018). Consistently, in the different models of this study,
MDA5 did not induce the production of IFNs, but provoked a non-ca-
nonical IFN-like response. Similar actions have been previously ob-
served for RIG-I and IFN regulatory factor 1 (IRF1) in inhibiting HEV
replication in epithelial cell lines (Xu et al., 2016, 2017).
Mechanistically, this remains an intriguing question that how these
broad antiviral factors can trigger ISG transcription without the re-
quirement of IFN production?
It has been previously reported that RIG-I overexpression triggers
STAT1 expression and activation (Xu et al., 2017; Jiang et al., 2011).
Similarly, we found that overexpression of MDA5 also activates STAT1
expression and phosphorylation at the 701 site. STAT1 phosphorylation
is the hallmark of JAK-STAT activation cascade, the downstream cas-
cade of IFN pathway. Interestingly, genetic silencing of STAT1 or
pharmacological imbibition of JAK-STAT pathway only partially atte-
nuated ISG induction and antiviral activity of MDA5, whereas com-
pletely blocked IFN-α-induced ISG transcription and antiviral activity.
It has been reported that these non-classical antiviral mechanisms are
also very important in antiviral defense. For instance, there are dif-
ferent forms of ISGF3 complexes, and some function independent of the
JAK-STAT pathway. Unphosphorylated ISGF3 (u-ISGF3) complex has
been demonstrated to drive antiviral ISG expression and protect from
viral infections at homeostatic status (Wang et al., 2017; Sung et al.,
2015). The STAT2-IRF9 complex can also regulate antiviral activity and
ISG expression without the presence of STAT1 (Blaszczyk et al., 2015).
Thus, our findings on MDA5 have added new knowledge to the non-
classical IFN responses.
In summary, MDA5 potently inhibits the infection of enteric viruses,
including HEV, HuNV and rotavirus. It provokes an antiviral IFN-like
response without requirement of IFN production, but is partially de-
pendent on the JAK-STAT cascade. These findings have revealed non-
canonical actions of MDA5 on viral infections, and the detailed me-
chanisms deserve further investigation.
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